T Cell Activation in Lupus Proteomic Characterization
狼疮蛋白质组表征中的 T 细胞激活
基本信息
- 批准号:6953252
- 负责人:
- 金额:$ 8.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-09-30 至 2007-06-30
- 项目状态:已结题
- 来源:
- 关键词:T cell receptorT lymphocyteautoantibodyautoimmunitybiological signal transductioncell proliferationgene mutationgenetic straingenetic susceptibilitygenetically modified animalshelper T lymphocyteimmune tolerance /unresponsivenessimmunogeneticslaboratory mouseleukocyte activation /transformationphenotypeposttranslational modificationsprotein quantitation /detectionproteomicssystemic lupus erythematosus
项目摘要
DESCRIPTION (provided by applicant):
Systemic lupus erythematosus (SLE) is characterized by IgG autoantibodies to ubiquitous intracellular components. Several inbred mouse strains also develop spontaneous lupus, with the same spectrum of autoantibodies. Certain of these specificities are pathogenic, including those directed against chromatin that induces immune-complex glomerulonephritis. Such autoantibodies in lupus appear to arise as a consequence of autoantigen-specific CD4 + T cell help. While the mechanisms of tolerance escape for T cells responsive to ubiquitous self peptides are unknown, central (thymic) T cell tolerance appears intact in spontaneous lupus; thus, a peripheral defect(s) presumably leads to activation of autoreactive T cells in this disorder. The hypothesis to be addressed in this proposal is that naive CD4 + T cells from lupus-prone MRL mice have intrinsic (genetic) defects that, compared to non-autoimmune T cells, render them hyperresponsive after T cell receptor (TCR)-CD3 complex contact with self-peptides, a defect(s) that contributes to tolerance loss with expansion of autoreactive T cells in secondary lymphoid organs. This hypothesis is based upon published work that naive T cells from Fas (CD95)-intact, lupus-prone MRL (MRL/+ FaS/lpr) mice are hyper-proliferative after TCR stimulation in vitro, compared to T cells from nonautoimmune mice, and that such T cells avoid peripheral tolerance induction in vivo. This data suggests that these differences are integral to the lupus phenotype, rather than reflective of differences in strains, a belief bolstered in part by the finding that T cells from humans with SLE have a similar hyper- proliferative phenotype after TCR engagement in vitro. In this proposal, the biochemical mechanisms responsible for the hyper-proliferative phenotype of CD4 + T cells in lupus will be addressed using state of- the art proteomic analysis to determine if the observed phenotypic differences in CD4 + T cell activation are associated with alterations in protein expression compared to control cells.
描述(由申请人提供):
系统性红斑狼疮(SLE)的特征是针对普遍存在的细胞内成分的IgG自身抗体。几个近交系小鼠品系也发展为自发性狼疮,具有相同的自身抗体谱。这些特异性中的某些是致病性的,包括那些针对诱导免疫复合物肾小球肾炎的染色质。狼疮中的这种自身抗体似乎是自身抗原特异性CD 4 + T细胞帮助的结果。虽然对普遍存在的自身肽应答的T细胞的耐受逃逸的机制是未知的,但在自发性狼疮中,中枢(胸腺)T细胞耐受似乎是完整的;因此,外周缺陷可能导致这种疾病中自身反应性T细胞的活化。本提案中要解决的假设是,来自狼疮易感MRL小鼠的幼稚CD 4 + T细胞具有内在(遗传)缺陷,与非自身免疫T细胞相比,这些缺陷使它们在T细胞受体(TCR)-CD 3复合物与自身肽接触后具有高反应性,这种缺陷导致耐受性丧失,伴随次级淋巴器官中自身反应性T细胞的扩增。该假设基于已发表的工作,即与来自非自身免疫小鼠的T细胞相比,来自Fas(CD 95)-完整、狼疮倾向MRL(MRL/+ FaS/lpr)小鼠的初始T细胞在体外TCR刺激后过度增殖,并且此类T细胞避免了体内外周耐受诱导。该数据表明,这些差异是狼疮表型的组成部分,而不是反映菌株的差异,这一观点部分得到以下发现的支持:来自患有SLE的人的T细胞在体外TCR接合后具有类似的过度增殖表型。在该提案中,将使用最先进的蛋白质组学分析来解决负责狼疮中的CD 4 + T细胞的过度增殖表型的生化机制,以确定与对照细胞相比,观察到的CD 4 + T细胞活化的表型差异是否与蛋白质表达的改变相关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joseph Edgar Craft其他文献
Joseph Edgar Craft的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joseph Edgar Craft', 18)}}的其他基金
Human and Translational Immunology Training Program
人类和转化免疫学培训计划
- 批准号:
10649548 - 财政年份:2021
- 资助金额:
$ 8.18万 - 项目类别:
Human and Translational Immunology Training Program
人类和转化免疫学培训计划
- 批准号:
10270035 - 财政年份:2021
- 资助金额:
$ 8.18万 - 项目类别:
Human and Translational Immunology Training Program
人类和转化免疫学培训计划
- 批准号:
10474483 - 财政年份:2021
- 资助金额:
$ 8.18万 - 项目类别:
Follicular Helper T Cell Function in Autoimmunity
滤泡辅助 T 细胞在自身免疫中的功能
- 批准号:
10320436 - 财政年份:2018
- 资助金额:
$ 8.18万 - 项目类别:
Follicular Helper T Cell Function in Autoimmunity
滤泡辅助 T 细胞在自身免疫中的功能
- 批准号:
10061557 - 财政年份:2018
- 资助金额:
$ 8.18万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 8.18万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 8.18万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 8.18万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 8.18万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 8.18万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 8.18万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 8.18万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 8.18万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 8.18万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 8.18万 - 项目类别:
Discovery Grants Program - Individual